| Product Information |
|
| Registration Number |
BR-1466
|
| Generic Name |
Anifrolumab
|
| Brand Name |
Saphnelo
|
| Dosage Strength |
300 mg/2 mL (150 mg/ml)
|
| Dosage Form |
Concentrate for Solution for
Infusion (IV)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
2 mL net content Type I clear and colorless glass vial, sealed with tefloncoated chlorobutyl elastomer stopper. and secured by aluminium seal with flip-off plastic button (Box of 1 vial)
.
|
| Pharmacologic Category |
Monoclonal Antibody.
|
| Manufacturer |
AstraZeneca Nijmegen B.V.
|
| Country of Origin |
Netherlands
|
| Trader |
|
| Importer |
AstraZeneca Pharmaceuticals (Phils.), Inc.
|
| Distributor |
|
| Application Type |
Monitored Release
|
| Issuance Date |
14 February 2024
|
| Expiry Date |
14 February 2029
|